Compare CVS Health Corp (CVS) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Shell PLC — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while Shell PLC trades at $99 (market cap $275.54B). The key difference: Shell PLC is far larger — about 2.4× CVS Health Corp's market cap, and Shell PLC pays the higher dividend (3.23%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Shell PLC for 90 Days on average.
| CVS | SHEL | |
|---|---|---|
Market Cap | $112.49B | $275.54B |
Volume | 8,467,392 | 4,925,662 |
Sector | Health | Energy |
52-Week High | $110.60 | $100.20 |
52-Week Low | $70.08 | $70.31 |
Typical Hold Time | 83 Days | 90 Days |
Enterprise Value | $174.83B | $317.24B |
Dividend Yield | 3.02% | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Shell (SHEL) trades at $96.85, down 0.79% on the day, with strong technical momentum indicated by bullish moving averages and a 52-week high near $99.16. The company shows solid fundamentals with a P/E of 10.71 and ROE of 14.35%, while recent earnings beat expectations in Q1 and Q2 2026. Key developments include the approval of LNG Canada Phase 2 expansion, doubling export capacity, and strategic portfolio optimization through asset divestments.
Outlook remains positive with analyst consensus at Buy (61.5%) and a $102.53 price target, though risks include volatile energy prices and execution challenges in major projects. The stock offers value through attractive valuation metrics and growth in LNG operations, supported by strong cash flow generation despite recent revenue declines from 2022 peaks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
